The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

Synthetic Biologics Provides Update on Development of SYN-004 (ribaxamase), for the Prevention of C. difficile Infection
Infectious Disease & AMR

Synthetic Biologics Provides Update on Development of SYN-004 (ribaxamase), for the Prevention of C. difficile Infection

APR 23, 2018
AOBiome Therapeutics Expands Clinical-Stage Pipeline, Initiates Phase 2 Clinical Trial for Episodic Migraine
Clinical & Manufacturing

AOBiome Therapeutics Expands Clinical-Stage Pipeline, Initiates Phase 2 Clinical Trial for Episodic Migraine

APR 23, 2018
Prota Therapeutics Partners With World Leading Bioscience Company, Chr. Hansen
Oncology

Prota Therapeutics Partners With World Leading Bioscience Company, Chr. Hansen

APR 20, 2018
Dannon® Awards $50,000 in Student Grants to Further Yogurt and Gut Microbiome Exploration
Pharma & Human Health

Dannon® Awards $50,000 in Student Grants to Further Yogurt and Gut Microbiome Exploration

APR 18, 2018
Optibiotix Health plc Signs 5 year Exclusive Agreement with Trigen Pharma
Pharma & Human Health

Optibiotix Health plc Signs 5 year Exclusive Agreement with Trigen Pharma

APR 18, 2018
Landmark Study To Address Global Malnutrition And Restorative Effect Of Infant Probiotic
Biotics and Supplements

Landmark Study To Address Global Malnutrition And Restorative Effect Of Infant Probiotic

APR 17, 2018
WACKER Strengthens Its Pharmaceutical-Protein Business and Buys SynCo Bio Partners
Finance

WACKER Strengthens Its Pharmaceutical-Protein Business and Buys SynCo Bio Partners

APR 17, 2018
MicroBiome Therapeutics Launches Clinically-Tested Dietary Supplement Engineered to Modulate the Gut Microbiome
Biotics and Supplements

MicroBiome Therapeutics Launches Clinically-Tested Dietary Supplement Engineered to Modulate the Gut Microbiome

APR 11, 2018
Second Genome Presents Clinical and Preclinical Data Supporting Development of Its P2X7 Inhibitor, SGM-1019, in NASH at the EASL International Liver Congress 2018
Clinical & Manufacturing

Second Genome Presents Clinical and Preclinical Data Supporting Development of Its P2X7 Inhibitor, SGM-1019, in NASH at the EASL International Liver Congress 2018

APR 9, 2018
Synlogic Announces Registered Direct Offering of Common Stock
Biotics and Supplements

Synlogic Announces Registered Direct Offering of Common Stock

APR 6, 2018
Finch Therapeutics and Takeda Announce Global Collaboration to Develop Microbiome Therapeutics in Inflammatory Bowel Disease (IBD)
Finance

Finch Therapeutics and Takeda Announce Global Collaboration to Develop Microbiome Therapeutics in Inflammatory Bowel Disease (IBD)

APR 5, 2018